Purple Biotech (PPBT) Shares Outstanding (Weighted Average) (2017 - 2021)
Purple Biotech (PPBT) has disclosed Shares Outstanding (Weighted Average) for 5 consecutive years, with $17.6 million as the latest value for Q4 2021.
- On a quarterly basis, Shares Outstanding (Weighted Average) rose 52.76% to $17.6 million in Q4 2021 year-over-year; TTM through Dec 2021 was $17.6 million, a 52.76% increase, with the full-year FY2021 number at $17.6 million, up 52.76% from a year prior.
- Shares Outstanding (Weighted Average) was $17.6 million for Q4 2021 at Purple Biotech, up from $11.5 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $19.4 million in Q4 2019 to a low of $9.5 million in Q4 2017.
- A 5-year average of $14.4 million and a median of $14.2 million in 2018 define the central range for Shares Outstanding (Weighted Average).
- Peak YoY movement for Shares Outstanding (Weighted Average): crashed 40.62% in 2020, then soared 52.76% in 2021.
- Purple Biotech's Shares Outstanding (Weighted Average) stood at $9.5 million in 2017, then soared by 50.21% to $14.2 million in 2018, then skyrocketed by 36.34% to $19.4 million in 2019, then plummeted by 40.62% to $11.5 million in 2020, then skyrocketed by 52.76% to $17.6 million in 2021.
- Per Business Quant, the three most recent readings for PPBT's Shares Outstanding (Weighted Average) are $17.6 million (Q4 2021), $11.5 million (Q4 2020), and $19.4 million (Q4 2019).